Swedish Orphan Biovitrum AB (publ): management transactions · Finland · FIN-FSA FI:swedish-orphan-biovitrum-ab-publ-e3c7bc SE0000872095 FI FI · FIN-FSA Mcap 150.8Bn€ Healthcare
Browse the full insider trade history of Swedish Orphan Biovitrum AB (publ), a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Swedish Orphan Biovitrum AB (publ) has recorded 8 reports. Market capitalisation: €150.8bn. The latest transaction was filed on 25 March 2026 — Purchase. Among the most active insiders: Guido Oelkers. All data is openly available.
€446,604
1 ops.
Sell Volume
Financial data FY ended December 2025 · cache
Analyst consensus
13 analysts 308.00 € Target 456.77 €(+5%) 530.00 €
Income statement
Revenue 28.24 Bn€
Gross profit 21.99 Bn€ 78% margin
Net income 478.0 M€ 3.2% margin
Valuation
PER (trailing) 167.0x
PER (forward) 19.3x
P/Book 3.7x
Beta 0.26
Balance sheet & cash
Market cap 150.78 Bn€
Total debt 11.49 Bn€
Free Cash Flow 5.41 Bn€
Debt / Equity 47%
Profitability & ownership
ROE 2.3%
ROA 7.0%
% insiders 10.1%
% institutions 73.3%
Last declaration on 25 March 2026
Declarations 8 total
Executives ● Purchase18 FIN-FSA
€53,493 1,366 shares @ €39.16 0.0000% mcap 100.0% of flow SE0000872095⌘
Aktie
FI:A003X324-1 · 23 Mar 2026
Ideal exit: 18 Dec 2026 (T+270) Executives ● Purchase18 FIN-FSA
€72,383 1,900 shares @ €38.0965 0.0000% mcap 100.0% of flow SE0000872095⌘
Aktie
FI:A003V827-1 · 10 Feb 2026
Ideal exit: 7 Nov 2026 (T+270) Executives ● Purchase18 FIN-FSA
€1m 58,230 shares @ €19.0475 0.0007% mcap 100.0% of flow SE0000872095⌘
Aktie
FI:A003T242-1 · 31 Oct 2025
Ideal exit: 28 Jul 2026 (T+270) Executives ● Sale18 FIN-FSA
D
Daniel Rankin Annan medlem i bolagets administrations-, lednings- eller kontrollorgan €446,604 15,000 shares @ €29.7736 0.0003% mcap 100.0% of flow SE0000872095⌘
Aktie
FI:A003T253-1 · 28 Oct 2025
Executives ● Purchase36 FIN-FSA
€2m 80,000 shares @ €19.0475 0.0010% mcap 41.3% of flow SE0000872095⌘
Aktie
FI:A003T241-1 · 31 Oct 2025
Ideal exit: 28 Jul 2026 (T+270) Executives ● Purchase29 FIN-FSA
€2m 80,000 shares @ €19.0392 0.0010% mcap 41.3% of flow SE0000872095⌘
Aktie
FI:A003T155-1 · 28 Oct 2025
Ideal exit: 25 Jul 2026 (T+270) Executives ● Purchase18 FIN-FSA
L
Lydia Abad-Franch Annan medlem i bolagets administrations-, lednings- eller kontrollorgan €916,913 48,026 shares @ €19.092 0.0006% mcap 100.0% of flow SE0000872095⌘
Aktie
FI:A003T126-1 · 24 Oct 2025
Ideal exit: 21 Jul 2026 (T+270) Executives ● Purchase27 FIN-FSA
€640,575 33,622 shares @ €19.0523 0.0004% mcap 17.4% of flow SE0000872095⌘
Aktie
FI:A003T122-1 · 27 Oct 2025
Ideal exit: 24 Jul 2026 (T+270)